Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common SharesNovember 20, 2025 7:30 AM EST | Source: Medexus Pharmaceuticals Inc.Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 20, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the Toronto Stock Exchange has accepted Medexus's notice of intention to make a normal course issuer bid, or NCIB, for its common shares (TSX: MDP). Under the NCIB, Medexus may purchase for cancellat ...